S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
TSE:CRON

Cronos Group (CRON) Stock Price, News & Analysis

C$3.55
-0.11 (-3.01%)
(As of 03/28/2024 ET)
Today's Range
C$3.55
C$3.75
50-Day Range
C$2.62
C$3.66
52-Week Range
C$2.15
C$3.75
Volume
452,820 shs
Average Volume
183,572 shs
Market Capitalization
C$1.35 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$2.77
CRON stock logo

About Cronos Group Stock (TSE:CRON)

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

CRON Stock Price History

CRON Stock News Headlines

Cronos Group (TSE:CRON) Shares Up 1.9%
“The Stock Market’s Bull Run is Far from Over” -Barrons
Barron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!
CRON Oct 2024 2.500 put
“The Stock Market’s Bull Run is Far from Over” -Barrons
Barron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!
Cronos Group Inc CRON
Cronos Group Inc (CRON)
Cronos Enters Australian Cannabis Market
12 Best CBD Stocks To Buy Now
See More Headlines
Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/29/2024
Next Earnings (Estimated)
5/07/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
447
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$2.77
High Stock Price Target
C$2.82
Low Stock Price Target
C$2.72
Potential Upside/Downside
-22.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
C$-69,850,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$87.24 million
Cash Flow
C$2.12 per share
Book Value
C$2.88 per share

Miscellaneous

Free Float
N/A
Market Cap
C$1.35 billion
Optionable
Not Optionable
Beta
1.04
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Michael Ryan Gorenstein J.D. (Age 37)
    President, CEO & Chairman
    Comp: $5.3M
  • Mr. James Holm (Age 41)
    Chief Financial Officer
    Comp: $422.9k
  • Mr. Jeffrey David Jacobson (Age 38)
    Chief Growth Officer
    Comp: $982.37k
  • Ms. Anna Shlimak (Age 38)
    Senior Vice President of Corporate Affairs & Strategy
    Comp: $713.79k
  • Mr. James Andrew McGinness III (Age 45)
    VP, Controller & Principal Accounting Officer
  • Mr. Shayne J. Laidlaw
    Director of Investor Relations & Strategy
  • Mr. Terry Gregory-Joseph Doucet (Age 34)
    General Counsel & Corporate Secretary
  • Ms. Shannon Buggy (Age 54)
    Senior VP & Global Head of People
    Comp: $590.42k
  • Mr. Arye Weigensberg (Age 41)
    Senior VP & Head of Research and Development

CRON Stock Analysis - Frequently Asked Questions

Should I buy or sell Cronos Group stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CRON shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRON, but not buy additional shares or sell existing shares.
View CRON analyst ratings
or view top-rated stocks.

What is Cronos Group's stock price target for 2024?

2 brokerages have issued 12 month price objectives for Cronos Group's shares. Their CRON share price targets range from C$2.72 to C$2.82. On average, they anticipate the company's stock price to reach C$2.77 in the next year. This suggests that the stock has a possible downside of 22.0%.
View analysts price targets for CRON
or view top-rated stocks among Wall Street analysts.

How have CRON shares performed in 2024?

Cronos Group's stock was trading at C$2.77 at the beginning of the year. Since then, CRON stock has increased by 28.2% and is now trading at C$3.55.
View the best growth stocks for 2024 here
.

When is Cronos Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our CRON earnings forecast
.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria (APHA), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS) and Intel (INTC).

How do I buy shares of Cronos Group?

Shares of CRON stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:CRON) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners